BIOMAT Database Logo BIOMAT Database Logo

Plasma thromboglobulin and platelet aggregation index in transient ischaemic attack: effect of aspirin and dipyridamole therapy. 1983

Z Aushri, and V Berginer, and I Nathan, and A Dvilansky

Beta-thromboglobulin (beta TG) plasma levels and platelet aggregation index (PAI) were determined in 14 transient ischaemic attack (TIA) patients, before and two weeks after starting therapy with aspirin and dipyridamole. Thirty healthy men were the control group. Decrement in beta TG plasma levels (without statistical significance) was found in treated patients when compared to the period before treatment. It is noteworthy that both these levels were significantly higher than plasma beta TG levels of normal controls. A highly significant difference was found between PAI of patients before treatment compared with PAI of patients treated with aspirin and dipyridamole. PAI was higher and similar to PAI of controls in the treated patients. No correlation between these two tests was established. It is concluded that the beta TG test is efficient as an aid for diagnosis of TIA, while PAI is better tool for follow-up.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D002546 Ischemic Attack, Transient Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6) Brain Stem Ischemia, Transient,Cerebral Ischemia, Transient,Crescendo Transient Ischemic Attacks,Transient Ischemic Attack,Anterior Circulation Transient Ischemic Attack,Brain Stem Transient Ischemic Attack,Brain TIA,Brainstem Ischemia, Transient,Brainstem Transient Ischemic Attack,Carotid Circulation Transient Ischemic Attack,Posterior Circulation Transient Ischemic Attack,TIA (Transient Ischemic Attack),Transient Ischemic Attack, Anterior Circulation,Transient Ischemic Attack, Brain Stem,Transient Ischemic Attack, Brainstem,Transient Ischemic Attack, Carotid Circulation,Transient Ischemic Attack, Posterior Circulation,Transient Ischemic Attack, Vertebrobasilar Circulation,Transient Ischemic Attacks, Crescendo,Vertebrobasilar Circulation Transient Ischemic Attack,Attack, Transient Ischemic,Attacks, Transient Ischemic,Brainstem Ischemias, Transient,Cerebral Ischemias, Transient,Ischemia, Transient Brainstem,Ischemia, Transient Cerebral,Ischemias, Transient Brainstem,Ischemias, Transient Cerebral,Ischemic Attacks, Transient,TIA, Brain,TIAs (Transient Ischemic Attack),Transient Brainstem Ischemia,Transient Cerebral Ischemia,Transient Cerebral Ischemias,Transient Ischemic Attacks
D004176 Dipyridamole A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) Antistenocardin,Apo-Dipyridamole,Cerebrovase,Cléridium,Curantil,Curantyl,Dipyramidole,Kurantil,Miosen,Novo-Dipiradol,Persantin,Persantine,Apo Dipyridamole,Novo Dipiradol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic
D001609 Beta-Globulins Serum proteins with an electrophoretic mobility that falls between ALPHA-GLOBULINS and GAMMA-GLOBULINS. Beta(1)CA Globulin,Beta-Globulin,Beta Globulin,Beta Globulins
D001620 beta-Thromboglobulin A platelet-specific protein which is released when platelets aggregate. Elevated plasma levels have been reported after deep venous thrombosis, pre-eclampsia, myocardial infarction with mural thrombosis, and myeloproliferative disorders. Measurement of beta-thromboglobulin in biological fluids by radioimmunoassay is used for the diagnosis and assessment of progress of thromboembolic disorders. beta-2 Thromboglobulin,Thromboglobulin, beta-2,beta 2 Thromboglobulin,beta Thromboglobulin

Related Publications

Z Aushri, and V Berginer, and I Nathan, and A Dvilansky
The use of aspirin and dipyridamole in the treatment of acute ischaemic stroke/transient ischaemic attack: an audit-based discussion.
April 2009, Clinical medicine (London, England),
Z Aushri, and V Berginer, and I Nathan, and A Dvilansky
[Plasma beta-thromboglobulin and platelet aggregation in vibration syndromes].
January 1987, Sangyo igaku. Japanese journal of industrial health,
Z Aushri, and V Berginer, and I Nathan, and A Dvilansky
Effects of dipyridamole and aspirin on shear-induced platelet aggregation in whole blood and platelet-rich plasma.
January 2002, Cerebrovascular diseases (Basel, Switzerland),
Z Aushri, and V Berginer, and I Nathan, and A Dvilansky
Transient ischaemic attacks and increased platelet aggregability associated with oral contraceptives. Treatment with dipyridamole and aspirin.
January 1977, Journal of neurology, neurosurgery, and psychiatry,
Z Aushri, and V Berginer, and I Nathan, and A Dvilansky
Dipyridamole potentiates the inhibition of platelet aggregation by aspirin (in human platelet rich plasma and whole blood).
January 1991, Journal of lipid mediators,
Z Aushri, and V Berginer, and I Nathan, and A Dvilansky
Enhanced plasma beta-thromboglobulin in hypoxemia: effect of dipyridamole.
April 1981, The New England journal of medicine,
Z Aushri, and V Berginer, and I Nathan, and A Dvilansky
No effect of acetylsalicylic acid on B-thromboglobulin and platelet factor 4 plasma levels in patients with transient ischaemic attacks.
January 1986, Stroke,
Z Aushri, and V Berginer, and I Nathan, and A Dvilansky
Platelet aggregation and dipyridamole therapy in nephrotics.
January 1982, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
Z Aushri, and V Berginer, and I Nathan, and A Dvilansky
Aspirin and the prevention of stroke after transient ischaemic attack.
January 1986, Monographs on atherosclerosis,
Z Aushri, and V Berginer, and I Nathan, and A Dvilansky
Inhibition of platelet aggregation in whole blood by dipyridamole and aspirin.
April 1986, Thrombosis research,
Copied contents to your clipboard!